WOW!! Good find.. So much information: Inventor
Post# of 30028
Posted On: 09/02/2014 12:55:43 AM
WOW!! Good find.. So much information:
Inventor: Wen, Rong (Bascom Palmer Eye Institute)
http://bascompalmer.org/researchers/profile/133038
Research Summary
As a retinal cell biology lab, we focus on the changes in photoreceptor behaviors under different circumstances. Specifically, we are interested in the mechanism that regulates light-induced photoreceptor plasticity and the role of Müller cells in this regulatory mechanism. We are also trying to understand the mechanisms for photoreceptor degeneration, including hereditary retinal degeneration and age-related macular degeneration (AMD), and to search for potential treatments. In addition, we are developing experimental models to mimic human ocular vascular disorders including choroidal neovascularization (CNV) and diabetic retinopathy. The goal is to understand the biology of the retina and photoreceptors, the physiopathology of retinal diseases, and to translate the bench research to patient care.
In addition:
In regards to MANF and CDNF, on the patent submitted he states: " While these two proteins have been considered to be potential treatments for Parkinson's disease, the inventor herein has considered them to be potential treatments for other neurodegeneratvie disorders, including retinal degenerative disorders, such as inherited retinal disorders, age-related macular degeneration, and glaucoma. "
SONIC BOOM!!
Inventor: Wen, Rong (Bascom Palmer Eye Institute)
http://bascompalmer.org/researchers/profile/133038
Research Summary
As a retinal cell biology lab, we focus on the changes in photoreceptor behaviors under different circumstances. Specifically, we are interested in the mechanism that regulates light-induced photoreceptor plasticity and the role of Müller cells in this regulatory mechanism. We are also trying to understand the mechanisms for photoreceptor degeneration, including hereditary retinal degeneration and age-related macular degeneration (AMD), and to search for potential treatments. In addition, we are developing experimental models to mimic human ocular vascular disorders including choroidal neovascularization (CNV) and diabetic retinopathy. The goal is to understand the biology of the retina and photoreceptors, the physiopathology of retinal diseases, and to translate the bench research to patient care.
In addition:
In regards to MANF and CDNF, on the patent submitted he states: " While these two proteins have been considered to be potential treatments for Parkinson's disease, the inventor herein has considered them to be potential treatments for other neurodegeneratvie disorders, including retinal degenerative disorders, such as inherited retinal disorders, age-related macular degeneration, and glaucoma. "
SONIC BOOM!!
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼